Linde plc Ordinary Shares (LIN)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ
Market Cap: $241.51B
Last updated: Nov 17, 2026 at 11:06 AM ET
Linde plc Ordinary Shares (LIN) Financials: Revenue, Profit and Cash Flow
Linde plc Ordinary Shares reported revenue of $33.99B for the fiscal year ended Dec 31, 2025, up 3.0% from the year before. That year, net income was $7.06B with a net margin of 20.8%, operating cash flow was $10.35B and free cash flow was $5.09B. The quarter ended Sep 30, 2026 had revenue of $9.40B and net income of $1.74B.
Revenue and Margins
The operating margin was 26.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $10.53B, a compound annual rate of 13.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $33.99B | +3.0% | 48.8% | 26.3% | 20.8% |
| Dec 2024 | $33.01B | +0.5% | 48.1% | 26.2% | 20.4% |
| Dec 2023 | $32.85B | -1.5% | 46.8% | 24.4% | 19.3% |
| Dec 2022 | $33.36B | +8.3% | 41.7% | 16.1% | 12.8% |
| Dec 2021 | $30.79B | +13.0% | 43.0% | 16.2% | 12.9% |
| Dec 2020 | $27.24B | -3.5% | 43.5% | 12.2% | 9.6% |
| Dec 2019 | $28.23B | +90.3% | 41.0% | 10.4% | 8.4% |
| Dec 2018 | $14.84B | +30.6% | 39.2% | 35.4% | 29.7% |
| Dec 2017 | $11.36B | +7.8% | 43.8% | 21.5% | 11.5% |
| Dec 2016 | $10.53B | N/A | 44.4% | 21.3% | 14.6% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 4.7% from the year before. In the quarter ended Sep 2026, net income fell 11.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.99B | $33.01B | $32.85B | $33.36B | $30.79B | $27.24B | $28.23B | $14.84B | $11.36B | $10.53B |
| Cost of revenue | $17.39B | $17.14B | $17.49B | $19.45B | $17.54B | $15.38B | $16.64B | $9.02B | $6.38B | $5.86B |
| Gross profit | $16.60B | $15.86B | $15.36B | $13.91B | $13.25B | $11.86B | $11.58B | $5.82B | $4.98B | $4.68B |
| Research and development | $147.00M | $150.00M | $146.00M | $143.00M | $143.00M | $152.00M | $184.00M | $113.00M | $93.00M | $92.00M |
| Operating income | $8.92B | $8.63B | $8.02B | $5.37B | $4.98B | $3.32B | $2.93B | $5.25B | $2.44B | $2.25B |
| Net income | $7.06B | $6.74B | $6.34B | $4.28B | $3.96B | $2.63B | $2.38B | $4.41B | $1.31B | $1.54B |
| EBITDA | $12.91B | $12.61B | $12.00B | $9.81B | $9.81B | $8.13B | $7.65B | $7.45B | $3.63B | $3.36B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.40B | $9.29B | $8.78B | $8.76B | $8.62B | $8.49B | $8.11B | $8.28B | $8.36B | $8.27B | $8.10B | $8.30B |
| Gross profit | $4.44B | $4.43B | $4.26B | $4.22B | $4.24B | $4.19B | $3.96B | $3.96B | $4.00B | $4.02B | $3.88B | $3.87B |
| Operating income | $2.15B | $2.55B | $2.44B | $2.02B | $2.37B | $2.35B | $2.18B | $2.27B | $2.09B | $2.18B | $2.10B | $2.03B |
| Net income | $1.74B | $1.97B | $1.90B | $1.57B | $1.97B | $1.81B | $1.71B | $1.77B | $1.60B | $1.70B | $1.67B | $1.58B |
Balance Sheet
As of Dec 2025, total debt of $26.99B exceeded cash and equivalents by $21.93B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $86.82B | $80.15B | $80.81B | $79.66B | $81.61B | $88.23B | $86.61B | $93.39B | $20.44B | $19.33B |
| Current assets | $13.32B | $12.95B | $12.62B | $13.05B | $10.16B | $10.92B | $10.35B | $17.27B | $3.29B | $2.88B |
| Cash and equivalents | $5.06B | $4.85B | $4.66B | $5.44B | $2.82B | $3.75B | $2.70B | $4.47B | $617.00M | $524.00M |
| Total liabilities | $47.08B | $40.66B | $39.72B | $38.27B | $36.16B | $38.65B | $34.98B | $36.29B | $13.91B | $13.88B |
| Short-term debt | $6.31B | $6.28B | $5.98B | $5.72B | $2.87B | $4.00B | $3.26B | $3.01B | $1.22B | $598.00M |
| Long-term debt | $20.68B | $15.34B | $13.40B | $12.20B | $11.34B | $12.15B | $10.69B | $12.29B | $7.78B | $8.92B |
| Shareholder equity | $38.24B | $38.09B | $39.72B | $40.03B | $44.03B | $47.32B | $49.07B | $51.60B | $6.02B | $5.02B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $88.08B | $88.35B | $86.31B | $86.82B | $85.99B | $86.08B | $82.70B | $80.15B | $82.55B | $80.22B | $80.35B | $80.81B |
| Total liabilities | $47.08B | $47.72B | $46.22B | $47.08B | $45.91B | $46.09B | $43.24B | $40.66B | $41.94B | $40.66B | $40.12B | $39.72B |
| Cash and equivalents | $3.95B | $4.90B | $3.96B | $5.06B | $4.51B | $4.79B | $5.29B | $4.85B | $5.19B | $4.63B | $4.85B | $4.66B |
| Shareholder equity | $39.42B | $39.08B | $38.57B | $38.24B | $38.62B | $38.52B | $38.03B | $38.09B | $39.17B | $38.18B | $38.83B | $39.72B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 49.2% of operating cash flow. Dividends and share repurchases together came to 145.6% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.35B | $9.42B | $9.30B | $8.86B | $9.72B | $7.43B | $6.01B | $3.70B | $2.92B | $2.79B |
| Capital expenditures | $5.26B | $4.50B | $3.79B | $3.17B | $3.09B | $3.40B | $3.68B | $1.88B | $1.31B | $1.47B |
| Free cash flow | $5.09B | $4.93B | $5.52B | $5.69B | $6.64B | $4.03B | $2.33B | $1.82B | $1.61B | $1.32B |
| Dividends paid | $2.81B | $2.65B | $2.48B | $2.34B | $2.19B | $2.03B | $1.89B | $1.17B | $901.00M | $856.00M |
| Share repurchases | $4.60B | $4.48B | $3.96B | $5.17B | $4.61B | $2.46B | $2.66B | $599.00M | $12.00M | $228.00M |
| Investing cash flow | -$5.72B | -$4.64B | -$4.67B | -$3.09B | -$3.01B | -$2.99B | $1.13B | $5.34B | -$1.31B | -$1.41B |
| Financing cash flow | -$4.55B | -$4.36B | -$5.40B | -$3.09B | -$7.59B | -$3.35B | -$8.99B | -$5.00B | -$1.66B | -$659.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.17B | $2.27B | $2.24B | $3.03B | $2.95B | $2.21B | $2.16B | $2.81B | $2.73B | $1.93B | $1.95B | $2.73B |
| Capital expenditures | $1.39B | $1.44B | $1.34B | $1.46B | $1.28B | $1.26B | $1.27B | $1.25B | $1.07B | $1.13B | $1.05B | $1.15B |
| Free cash flow | $1.78B | $833.00M | $898.00M | $1.57B | $1.67B | $954.00M | $891.00M | $1.56B | $1.67B | $796.00M | $906.00M | $1.58B |
Frequently Asked Questions About LIN
What is Linde plc Ordinary Shares' annual revenue?
Linde plc Ordinary Shares reported revenue of $33.99B for the fiscal year ended Dec 31, 2025.
How fast is Linde plc Ordinary Shares' revenue growing?
Revenue was up 3.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.6%.
Is Linde plc Ordinary Shares profitable?
Yes. Linde plc Ordinary Shares reported net income of $7.06B for the fiscal year ended Dec 31, 2025, with a net margin of 20.8%.
How much free cash flow does LIN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $10.35B minus capital expenditures of $5.26B produced free cash flow of $5.09B.
How much debt does Linde plc Ordinary Shares have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $20.68B, short-term debt of $6.31B and cash and equivalents of $5.06B.
LIN pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts